Breaking News

OPKO To Acquire FineTech

Healthcare group buys Israeli HPAPI maker

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

OPKO Health has entered into an agreement to acquire FineTech Pharmaceutical, an Israeli company that develops and produces high value, high potency APIs. The transaction is expected to close on December 29, 2011. Financial terms were not disclosed. FineTech possesses proprietary technology and know-how in several important areas of organic synthesis. The company offers a full range of services from paper chemistry and laboratory scale development to pilot scale and commercial production, and i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters